Why Eton Pharmaceuticals, Inc.’s (ETON) Stock Is Up 16.12%
As of Friday, November 06, Eton Pharmaceuticals, Inc.’s ETON share price has surged by 16.12%, which has investors questioning if this is right time to sell.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Rosalio Madrigal
Michael Rose
Jenna Brashear
Michael Rose
| Share Statistics | ETON | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,755.0 | $421.5 | 54% |
|
| Shares Out (Mil) | 33.3 | 46.9 | 38% |
|
| Institutional Ownership | 92.4% | 82.0% | 61% |
|
| Float (Mil) | 22.5 | 49.2 | 30% |
|
| Beta | 0.83 | 0.68 | 49% |
|
| Avg Daily Volume (000s) | 767 | 347 | 65% |
|
| Price Change (52-week) |
261.8% | 49.3% | 99% |
|
| Growth | ETON | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.4% | na |
|
| Net Income (5yr) | 30.3% | (1.3%) | 85% |
|
| EPS (5yr) | 33.7% | 15.1% | 84 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (1.4%) | (15.0%) | 63% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | $0.680 | $1.775 | $3.305 | |
| Month Ago EPS | $0.435 | $1.400 | $2.550 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 2 | 1 | |
| Three Months Ago EPS | $0.435 | $1.400 | $2.580 | |
| Year/Year Chg | (35.8%) | (1,138%) | (2,442%) | |
| Financials | ETON | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $141 | $275 | 29% |
|
| Net Income (TTM) (Mil) | $50 | ($11) | 54% |
|
| EPS (TTM) | $1.805 | ($0.700) | 69% |
|
| Operating Cash Flow (TTM) (Mil) | $38 | ($7) | 44% |
|
| Net Cash Flow (TTM) (Mil) | $19 | $1 | 62% |
|
| Long-Term Debt (Q1) (Mil) | $12 | $6 | 29% |
|
| Enterprise Value (Q1) (Mil) | $1,597 | $331 | 47% |
|
| Valuation | ETON | Industry Median |
Percentile (All Stocks) |
|
| P/B | 20.15 | 2.08 | 97% |
|
| P/E | 38.1 | 20.9 | 82% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 1.1 | 1.1 | 55% |
|
| Ratios | ETON | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 71.2% | 69.5% | 82% |
|
| Net Margin | 35.3% | 3.6% | 92% |
|
| ROA | 38.1% | (23.8%) | 99% |
|
| ROE | 90.6% | (24.2%) | 96% |
|
| Liabilities to Assets | 44.7% | 31.6% | 36% |
|
| F-Score | 7 | 3 | 82% |
|
Passing Stock Screens
As of 11/20/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 14.3% |
| +/- S&P 500: | +6.9 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors